Skip to content

Yunpi Yishen Jiedu Tongluo method for improving quality of life on advanced rheumatoid arthritis: a multicenter prospective cohort study

Yunpi Yishen Jiedu Tongluo method for improving quality of life on advanced rheumatoid arthritis: a multicenter prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005062
Enrollment
Unknown
Registered
2021-07-16
Start date
2021-07-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced rheumatoid arthritis

Interventions

Sponsors

Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the RA classification criteria of the 2010 ACR/EULAR; 2.DAS28<=3.2; 3. More than 3 joint deformities and dysfunctions; 4. Fatigue; 5. The medical history is greater than or equal to 5 years; 6. It is in line with the syndrome of TCM deficiency of spleen and kidney combined with dampness, poison and blood stasis; 7. 18 years old to 65 years old; 8. Patients informed and agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe organ disease or mental illness; 2. Patients who are allergic to the drugs involved in the study protocol or who have contraindications.

Design outcomes

Primary

MeasureTime frame
Quality of life score;Functional Assessment in Chronic Disease Treatment - Fatigue;Health Assessment Questionnaire Disability Index;

Secondary

MeasureTime frame
Physician's overall assessment of the patient's condition;General assessment of own condition;TCM syndrome score;Simplified Disease Activity Index;adverse event rate;RA color Doppler ultrasound joint semi-quantitative score;clinical disease activity index;Sharp van der Heijde score;pain visual analogue scale;

Countries

China

Contacts

Public ContactWen Chengping

Zhejiang Chinese Medical University

wengcp@163.com+86 13906514781

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026